التفاصيل البيبلوغرافية
العنوان:
Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza
المؤلفون:
Jules Hernández-Sánchez , Eduardo López-Medina , Dan Engelhard , Stefan Sturm , Margarita Baka , Jesús Saavedra-Lozano , Francisco Bautista , Carmelo Rizzari , Clare Nasmyth-Miller
المساهمون:
Bautista, F, Engelhard, D, Rizzari, C, Baka, M, Saavedra-Lozano, J, Lopez-Medina, E, Nasmyth-Miller, C, Hernandez-Sanchez, J, Sturm, S
المصدر:
Open Forum Infectious Diseases
بيانات النشر:
Oxford University Press, 2019.
سنة النشر:
2019
مصطلحات موضوعية:
0301 basic medicine , medicine.medical_specialty , Oseltamivir carboxylate , Oseltamivir , oseltamivir , viruses , Cmax , Viral resistance , Gastroenterology , 03 medical and health sciences , chemistry.chemical_compound , 0302 clinical medicine , Pharmacokinetics , children , Internal medicine , Medicine , 030212 general & internal medicine , Viral shedding , business.industry , Brief Report , virus diseases , clinical trial , respiratory tract diseases , immunocompromised , 030104 developmental biology , Infectious Diseases , Oncology , chemistry , Median time , Pharmacodynamics , business , influenza
الوصف:
This randomized phase 1b study evaluated the pharmacokinetics/pharmacodynamics of conventional-dose (30–75 mg twice daily [BID]) vs triple-dose (90–225 mg BID; weight-adjusted) oseltamivir for treatment of influenza in severely immunocompromised children
اللغة:
English
تدمد:
2328-8957
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66bd796064345dcc16dfc5400c47f558 http://europepmc.org/articles/PMC6809794
حقوق:
OPEN
رقم الأكسشن:
edsair.doi.dedup.....66bd796064345dcc16dfc5400c47f558
قاعدة البيانات:
OpenAIRE
